Neuro-oncology: a step towards clinical blood biomarkers of glioblastoma.
Glioblastoma is the most common primary brain tumour in adults, but— unlike many other cancers—no blood-based biomarkers are available for differential diagnosis, estimation of prognosis or monitoring of treatment response in glioblastoma. New research has detected three proteins with potential clinical value in the blood of patients with glioblastoma.